Consistent with the results of recent studies, which also analysed FOXP3 expression [40,41], we found significant increases in the percentage of all FOXP3+ cells among CD4+ T cells from patients with CLL. Here, FOXP3 is linked to B-cell chronic lymphocytic leukemia.